Real-World Experience Study of Elagolix For the Treatment of Endometriosis in Canada

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 4, 2019

Primary Completion Date

September 27, 2021

Study Completion Date

September 27, 2021

Conditions
Endometriosis
Trial Locations (18)

T3M 1M4

South Health Campus Rheumatology Clinic /ID# 213065, Calgary

T5T 1L6

Aubrey D. Uretsky Professional Corporation /ID# 214753, Edmonton

V6H 2N9

BC Women's Hospital /ID# 214561, Vancouver

A1A 4Y3

Strand Clinic /ID# 213567, St. John's

B3K 6R8

IWK Health Center /ID# 213066, Halifax

P3A 1W8

Medicor Research Inc /ID# 213467, Greater Sudbury

L8S 4K1

Hamilton Health Sciences - McMaster University Medical Centre /ID# 213496, Hamilton

N5X 2N7

Dr. George A. Vilos Medicine Professional Corporation /ID# 214497, London

K1H 8L6

Ottawa Hospital Research Institute /ID# 213608, Ottawa

M4N 3M5

Sunnybrook Health Sciences Ctr /ID# 214330, Toronto

M5B 1W8

Unity Health Toronto - St. Michael's Hospital /ID# 213590, Toronto

J8P 7H2

CISSS - Hôpital de Gatineau /ID# 212944, Gatineau

H8N 1T9

Jessima R&D Inc. /ID# 212943, LaSalle

J4N 1C2

Clinique de Gynecologie-Obstetrique Pierre Boucher /ID# 213064, Longueuil

H1T 2M4

CIUSSS de l'est de l'Ile-de-Montreal - Hopital Maisonneuve-Rosemont /ID# 213439, Montreal

H3T 1E2

Jewish General Hospital /ID# 215728, Montreal

H4A 3T2

Duplicate_Brunswick Medical /ID# 214743, Montreal

G1V 4G2

CHU de Quebec-Université Laval hôpital CHUL /ID# 213677, Québec

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY